| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/09/2001 | US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents |
| 01/09/2001 | US6171294 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 01/04/2001 | WO2001000577A2 Preparation of substituted piperidin-4-ones |
| 01/04/2001 | WO2001000206A1 Vla-4 inhibitor compounds |
| 01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 01/04/2001 | CA2370491A1 Preparation of substituted piperidin-4-ones |
| 01/04/2001 | CA2369308A1 Vla-4 inhibitor compounds |
| 01/03/2001 | EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments |
| 01/03/2001 | EP1063984A1 Inflammatory cell inhibitors |
| 01/03/2001 | EP1063982A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 01/03/2001 | CN1278821A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278793A Sulfonyl derivatives |
| 01/03/2001 | CN1278791A Process for the preparation of azacyclkylalkanoyl pseudotetrapeptides |
| 01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/03/2001 | CN1060175C Method for prepn. of 3-formyl-cephem derivatives |
| 01/03/2001 | CN1060039C Inhibition of smooth muscle cell migration by (R)-amlodipine |
| 01/02/2001 | US6169097 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives |
| 01/02/2001 | US6169075 Antitumor agent inhibiting the proliferation of a range of rapidly dividing tumour cells like melanoma and/or lymphoma cells |
| 01/02/2001 | CA2068064C Fibrinogen receptor antagonists |
| 01/02/2001 | CA2054850C Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/02/2001 | CA1341161C Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them |
| 12/28/2000 | WO2000078753A1 Process for the preparation of paroxetine and structurally related compounds |
| 12/28/2000 | WO2000078751A2 Compounds for use in treatment of neurological disorders |
| 12/28/2000 | WO2000078720A1 Novel dihydropyridine derivative |
| 12/28/2000 | WO2000078719A1 Dihydropyridine derivative |
| 12/28/2000 | WO2000078718A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans |
| 12/28/2000 | WO2000078716A1 α1B-ADRENERGIC RECEPTOR ANTAGONISTS |
| 12/28/2000 | WO2000078709A1 Vinylated alkoxyamine, use thereof, and process for producing the same |
| 12/28/2000 | WO2000078316A1 Use of nitroxides in wound healing and in the prevention of photodamage |
| 12/28/2000 | CA2341542A1 .alpha.1b-adrenergic receptor antagonists |
| 12/27/2000 | EP1063230A1 Cyclic amino compounds |
| 12/27/2000 | EP1062358A1 Novel method for preparing fexofenadine |
| 12/27/2000 | EP1062206A2 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis |
| 12/27/2000 | EP1061922A1 USE OF $i(N)-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS FOR TREATING HEPATITIS VIRUS INFECTIONS |
| 12/27/2000 | EP1061919A1 Novel opiate compounds, methods of making and methods of use |
| 12/27/2000 | EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
| 12/27/2000 | EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 12/27/2000 | CN1278255A Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 12/27/2000 | CN1278249A Biphenyl derivatives as pharmaceuticals |
| 12/27/2000 | CN1278244A Dipeptide nitriles |
| 12/27/2000 | CN1059898C Piperidine derivatives, prepn. method and use thereof |
| 12/26/2000 | US6166212 Process for the synthesis of N-(hydroxyalkoxy) substituted hindered amine stabilizers |
| 12/26/2000 | US6166050 Treatment of inflammatory and autoimmune diseases |
| 12/26/2000 | US6166039 Peripherally active anti-hyperalgesic opiates |
| 12/26/2000 | US6166035 1,4-dihydropyridine derivatives and their use in therapy |
| 12/26/2000 | US6166020 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 12/26/2000 | US6166011 For treatment of disorders arising from neurodegenerative diseases or other disorders involving nerve damage |
| 12/26/2000 | US6166009 For clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation |
| 12/26/2000 | US6166008 Treatment of schizophrenia with ampakines and neuroleptics |
| 12/26/2000 | US6166006 Having antagonistic activity on mcp-1 (monocyte chemoattractant protein-1) receptor; antiinflammatory agents |
| 12/21/2000 | WO2000077027A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076974A2 Oligomers and polymers of cyclic imino carboxylic acids |
| 12/21/2000 | WO2000076973A1 N-cyclopentyl modulators of chemokine receptor activity |
| 12/21/2000 | WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity |
| 12/21/2000 | WO2000076971A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076970A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076962A1 Thiol derivative, metallo-beta-lactamase inhibitors |
| 12/21/2000 | WO2000076514A1 Cyclopentyl modulators of chemokine receptor activity |
| 12/21/2000 | WO2000076513A1 Cyclopentyl modulators of chemokine receptor activity |
| 12/21/2000 | WO2000076512A1 Cyclopentyl modulators of chemokine receptor activity |
| 12/21/2000 | WO2000076511A1 Cyclopentyl modulators of chemokine receptor activity |
| 12/21/2000 | WO2000076510A1 Dermal anesthetic agents |
| 12/21/2000 | WO2000076504A1 Production of agglomerates of inogatran and the compound inogatran anhydrate |
| 12/21/2000 | WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 12/21/2000 | WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 12/21/2000 | CA2383008A1 Compounds |
| 12/21/2000 | CA2375920A1 Compounds |
| 12/21/2000 | CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 12/21/2000 | CA2374555A1 Thiol derivative, metallo-beta-lactamase inhibitors |
| 12/20/2000 | EP1061076A1 N-acyl cyclic amine derivatives |
| 12/20/2000 | EP1060178A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 12/20/2000 | EP1060175A2 Tryptase inhibitors |
| 12/20/2000 | EP1060171A2 Tryptase inhibitors |
| 12/20/2000 | EP1060162A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
| 12/20/2000 | EP1059922A2 Glycine transport inhibitors |
| 12/20/2000 | CN1277194A New 1- aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
| 12/20/2000 | CN1277192A New substituted pyridine or pyridine compound, their producing process and pharmaceutical composition containing them |
| 12/20/2000 | CN1059668C Process for producing N-aliphatic substituted p-phenylenediamines |
| 12/19/2000 | US6162919 Process for preparing the d-threo isomer of methylphenidate hydrochloride |
| 12/19/2000 | US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
| 12/19/2000 | US6162805 Use of an NK-1 receptor antagonist and an SSRI for treating obesity |
| 12/19/2000 | US6162425 A keratin-reducing agent without allergic and sensitizing reactions |
| 12/14/2000 | WO2000075172A2 FACTOR VIIa INHIBITORS |
| 12/14/2000 | WO2000075109A1 Ethanesulfonyl-piperidine derivatives |
| 12/14/2000 | WO2000075108A1 Inhibitors of metalloproteinases |
| 12/14/2000 | WO2000075107A2 Bradykinin receptor antagonists |
| 12/14/2000 | WO2000074681A1 Metalloprotease inhibitors |
| 12/14/2000 | WO2000046187A3 Antizyme modulators and their use |
| 12/14/2000 | CA2375882A1 Metalloprotease inhibitors |
| 12/14/2000 | CA2374460A1 Inhibitors of metalloproteinases |
| 12/13/2000 | EP1059302A1 Factor VIIa inhibitors |
| 12/13/2000 | EP1058698A1 Preparation for prevention and healing of inflammation affections |
| 12/13/2000 | EP1058684A1 Glycine transport inhibitors |
| 12/13/2000 | EP1058680A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 12/13/2000 | CN1276785A N-aroylphenylalanine derivs. |
| 12/12/2000 | US6160126 Useful in preparing guanidine derivatives useful as insecticides and miticides |
| 12/12/2000 | US6159979 Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity |
| 12/12/2000 | US6159973 Aromatic amides, their preparation process, the compositions containing them and their use as pesticides |
| 12/07/2000 | WO2000073271A1 Mutual salt of amlodipine and atorvastatin |